Can­cer biotech ends tri­al, search­es for sale or oth­er route

Aileron Ther­a­peu­tics has scrapped its tri­al, laid off most em­ploy­ees and is search­ing for a merg­er part­ner or oth­er strate­gic al­ter­na­tive.

The Boston biotech said …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER